Currently at Skin Cancer and Dermatology Institute we are offering several different studies treating Atopic dermatitis/eczema, Psoriasis, Hidradenitis, Notalgia paresthetica, Alopecia areata, and Alopecia totalis.

These studies are phase three studies offering cutting edge treatment for the above mentioned conditions aimed to treat both adolescents and adults.

We do offer a number of non-treatment studies as well aimed to follow patients who are currently on biologic therapy for their different skin conditions. This study is designed to observe safety data while they switch to different treatment modalities.

We also following patients who have been diagnosed with melanoma to follow their long term outcome.

All studies active and ongoing are listed on clinicaltrials.gov.

If you would like more information please feel free to directly reach out to our research team at 775-336-3665.